BR0307875A - Composição que pode ser administrada oralmente para a fotoproteção da pele - Google Patents

Composição que pode ser administrada oralmente para a fotoproteção da pele

Info

Publication number
BR0307875A
BR0307875A BR0307875-2A BR0307875A BR0307875A BR 0307875 A BR0307875 A BR 0307875A BR 0307875 A BR0307875 A BR 0307875A BR 0307875 A BR0307875 A BR 0307875A
Authority
BR
Brazil
Prior art keywords
skin
photoprotection
orally administered
administered composition
composition
Prior art date
Application number
BR0307875-2A
Other languages
English (en)
Other versions
BR0307875B1 (pt
Inventor
Lionel Breton
Isabelle Bureau-Franz
Chantal Fanchon
Original Assignee
Nestle Sa
Oreal L Oreal S A L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa, Oreal L Oreal S A L filed Critical Nestle Sa
Publication of BR0307875A publication Critical patent/BR0307875A/pt
Publication of BR0307875B1 publication Critical patent/BR0307875B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Medical Informatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"COMPOSIçãO QUE PODE SER ADMINISTRADA ORALMENTE PARA A FOTOPROTEçãO DA PELE". A presente invenção refere-se a uma composição que pode ser administrada oralmente para a fotoproteção da pele que compreende a combinação de i) pelo menos uma bactéria pró-biótica de ácido láctico ou um sobrenadante de cultura da mesma e (ii) pelo menos um carotenóide ou um derivado do mesmo, incluídos em um veículo oralmente aceitável.
BRPI0307875-2A 2002-02-21 2003-02-18 Uso de uma bactéria pró-biótica de ácido láctico ou de um sobrenadante de cultura da mesma e um carotenóide para a preparação de uma composição para a fotoproteção da pele BR0307875B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075703 2002-02-21
EP02075703.5 2002-02-21
PCT/EP2003/001685 WO2003070203A1 (en) 2002-02-21 2003-02-18 Orally administrable composition for the photoprotection of the skin

Publications (2)

Publication Number Publication Date
BR0307875A true BR0307875A (pt) 2004-12-28
BR0307875B1 BR0307875B1 (pt) 2014-12-23

Family

ID=27741186

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0307875-2A BR0307875B1 (pt) 2002-02-21 2003-02-18 Uso de uma bactéria pró-biótica de ácido láctico ou de um sobrenadante de cultura da mesma e um carotenóide para a preparação de uma composição para a fotoproteção da pele

Country Status (23)

Country Link
US (2) US20050069505A1 (pt)
EP (1) EP1478329B1 (pt)
JP (1) JP2005526038A (pt)
KR (1) KR20040096604A (pt)
CN (1) CN1301708C (pt)
AR (1) AR038594A1 (pt)
AT (1) ATE325604T1 (pt)
AU (1) AU2003232184B2 (pt)
BR (1) BR0307875B1 (pt)
CA (1) CA2477144C (pt)
DE (1) DE60305159T2 (pt)
DK (1) DK1478329T3 (pt)
ES (1) ES2263990T3 (pt)
HK (1) HK1079104A1 (pt)
MX (1) MXPA04008177A (pt)
NO (1) NO20043848L (pt)
PL (1) PL372146A1 (pt)
PT (1) PT1478329E (pt)
RU (1) RU2309760C2 (pt)
TW (1) TWI344845B (pt)
UA (1) UA77066C2 (pt)
WO (1) WO2003070203A1 (pt)
ZA (1) ZA200407551B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050106131A1 (en) * 2002-02-21 2005-05-19 Lionel Breton Photoprotective orally administrable composition for skin
DE60305159T2 (de) * 2002-02-21 2007-03-15 Société des Produits Nestlé S.A. Oral verabreichbare zusammensetzung zum schutz der haut vor licht
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
BRPI0417307A2 (pt) * 2003-12-04 2008-12-30 Biofilms Strategies Inc mÉtodos e composiÇÕes para impedir as formaÇÕes de biofilme, reduzindo os biofilmes existentes, e para reduzir os biofilmes existentes, e para reduzir as populaÇÕes de bactÉria
FR2876029B1 (fr) * 2004-10-04 2008-11-14 Oreal Composition cosmetique et/ou dermatologique pour peaux sensibles.
MX2007004135A (es) * 2004-10-04 2007-06-15 Oreal Composicion cosmetica y/o dermatologica para pieles sensibles.
US20060269508A1 (en) 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
WO2006110631A1 (en) 2005-04-08 2006-10-19 The Procter & Gamble Company Methods of use of orally administered probiotic bifidobacteria for human beauty benefits
AT501919B1 (de) * 2005-06-14 2008-09-15 Erber Ag Probiotischer, gesundheits- bzw. leistungsfördernder futtermittel- und/oder trinkwasserzusatz für tiere sowie seine verwendung
US20110082218A1 (en) * 2006-06-15 2011-04-07 Karin Wertz Treatment and modulation of gene expression and skin aging
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
FR2920304B1 (fr) 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
JP5860396B2 (ja) * 2009-05-11 2016-02-16 ネステク ソシエテ アノニム ラクトバチルス・ジョンソニーＬａ１ＮＣＣ５３３（ＣＮＣＭＩ−１２２５）及び免疫障害
FR2953408B1 (fr) * 2009-12-08 2013-02-08 Oreal Microorganismes probiotiques a titre d'actif pour l'eclat du teint de la peau
US20130004463A1 (en) * 2010-01-06 2013-01-03 Kabushiki Kaisha Yakult Honsha Dna damage repair promoter for oral application, and elastase activity inhibitor for oral application
WO2012002322A1 (ja) * 2010-06-28 2012-01-05 株式会社ヤクルト本社 経口用皮膚性状改善剤
US9259019B2 (en) * 2010-11-11 2016-02-16 Mars, Incorporated Bifidobacteriumstrain
EA028377B1 (ru) 2011-04-08 2017-11-30 Кр. Хансен А/С Противомикробная композиция
MY171851A (en) 2011-06-20 2019-11-04 Heinz Co Brands H J Llc Probiotic compositions and methods
US9113653B2 (en) * 2011-08-19 2015-08-25 Steven J Maranz Methods of administering probiotic organisms that synthesize carotenoid compounds in situ to enhance human health and nutrition
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
US10059919B2 (en) 2012-04-09 2018-08-28 Chr. Hansen A/S Bioprotection using Lactobacillus paracasei strains
EA036321B1 (ru) 2012-04-09 2020-10-26 Кр. Хансен А/С Штамм lactobacillus paracasei chcc12777 dsm24651, обладающий противогрибковыми свойствами
CN113730442A (zh) 2014-10-31 2021-12-03 潘德勒姆治疗公司 与病症的微生物治疗和诊断有关的方法和组合物
US20160271189A1 (en) * 2015-03-18 2016-09-22 Whole Biome, Inc. Methods and compositions relating to microbial treatment and diagnosis of skin disorders
KR20180056775A (ko) 2015-10-07 2018-05-29 갈데르마 리써어치 앤드 디벨로프먼트 유산균 함유 조성물 및 아토피 피부염을 치료하기 위한 이의 용도
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
US11207360B2 (en) * 2017-11-28 2021-12-28 NUTRAVIS S.r.l. Composition for the treatment of dysbiosis of the intestinal microbiota
DE102018000033A1 (de) * 2018-01-03 2019-07-25 Torsten Schott Verfahren zur beschleunigten Allgemein- und Hautregeneration sowie Wundheilung
GB202115797D0 (en) * 2021-11-03 2021-12-15 Iiaa Ltd Compositions comprising probiotic and postbiotic strains of bacteria

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US539773A (en) * 1895-05-21 Carburetor
US3920834A (en) * 1970-07-10 1975-11-18 Hoffmann La Roche Light-screening compositions and method
DE3024318A1 (de) * 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
US4646362A (en) * 1985-01-10 1987-03-03 Kimberly-Clark Corporation Disposable underpants, such as child's training pants and the like
US4806368A (en) * 1987-09-16 1989-02-21 Reddy Malireddy S Shelf life and subsequent growth of lactobacillus acidophilus, propionibacterium shermanii and leuconostoc citrovorum in dietary fiber based supplement preparation
US5223491A (en) * 1989-11-09 1993-06-29 Donzis Byron A Method for revitalizing skin by applying topically water insoluble glucan
CH680972A5 (pt) * 1990-09-28 1992-12-31 Nestle Sa
DE69219768T2 (de) * 1992-07-06 1997-08-28 Nestle Sa Milchbakterien
US5501857A (en) * 1992-07-24 1996-03-26 Midwestern Bio-Ag Products & Services, Inc. Oral nutritional and dietary composition
FR2698268B1 (fr) 1992-11-24 1995-01-20 Oreal Composition photoprotectrice administrée par voie orale.
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
FR2718752B1 (fr) 1994-04-15 1996-07-12 World Trust Investment Sa Préparations à base de lactosérum fermenté et leurs utilisations.
FR2725896B1 (fr) 1994-10-19 1996-11-29 Sederma Sa Nouvelles compositions cosmetiques ou dermopharmaceutiques
IT1274654B (it) 1995-02-28 1997-07-18 Newpharma Srl Associazioni di fermenti lattici e lisati di saccaromiceti loro uso terapeutico e composizioni che le contengono
FR2749758B1 (fr) * 1996-06-12 1998-08-07 Oenobiol Sa Lab Composition a activite bronzante et photoprotectrice et ses applications esthetiques
US6030650A (en) * 1996-11-22 2000-02-29 Princeton Nutrition, L.L.C. Complete nutritional milk compositions and products
EP0931543B1 (de) 1997-12-19 2002-03-20 MERCK PATENT GmbH Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
EP1067945B1 (en) * 1998-04-01 2006-01-04 Ganeden Biotech, Inc. Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
DE19819475A1 (de) * 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
EP1020123A1 (en) * 1999-01-18 2000-07-19 Sitia-Yomo S.p.A. Beverages containing live lactic bacteria
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
JP2001000142A (ja) * 1999-06-23 2001-01-09 Artnature Co Ltd 育毛および発毛用栄養補助食品
ATE512594T1 (de) * 1999-09-09 2011-07-15 Nestle Sa Verbesserung des zustandes älterer haustiere
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
US6617356B2 (en) * 2000-01-03 2003-09-09 Naturally Scientific Inc Gel system for oral and topical administration of water insoluble and/or water intolerant drugs and supplements
IL151596A0 (en) * 2000-03-24 2003-04-10 Nestle Sa Use of lactic acid bacterium for the treatment of peritonitis
EP1151673A3 (en) * 2000-05-03 2002-01-02 Societe Des Produits Nestle S.A. Confectionery product having a filling
CN100553646C (zh) * 2000-10-06 2009-10-28 雀巢产品股份有限公司 用乳酸菌微生态制剂调节皮肤免疫系统
US6864231B2 (en) 2001-01-09 2005-03-08 Pharmachem Laboratories, Inc. Glycoprotein matrix compositions and methods related thereto
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
ES2462535T3 (es) * 2002-02-21 2014-05-23 Societe des Produits Nestlé S.A. Composición de pienso para animales de compañía destinada a proteger la piel de la radiación solar
DE60305159T2 (de) * 2002-02-21 2007-03-15 Société des Produits Nestlé S.A. Oral verabreichbare zusammensetzung zum schutz der haut vor licht
US20050106131A1 (en) * 2002-02-21 2005-05-19 Lionel Breton Photoprotective orally administrable composition for skin

Also Published As

Publication number Publication date
CA2477144C (en) 2011-06-14
AR038594A1 (es) 2005-01-19
ES2263990T3 (es) 2006-12-16
NO20043848L (no) 2004-09-14
CN1301708C (zh) 2007-02-28
BR0307875B1 (pt) 2014-12-23
TWI344845B (en) 2011-07-11
UA77066C2 (en) 2006-10-16
US20070280999A1 (en) 2007-12-06
EP1478329B1 (en) 2006-05-10
US20050069505A1 (en) 2005-03-31
DE60305159T2 (de) 2007-03-15
US10688139B2 (en) 2020-06-23
MXPA04008177A (es) 2005-06-08
RU2004127986A (ru) 2005-05-10
ZA200407551B (en) 2005-10-12
EP1478329A1 (en) 2004-11-24
HK1079104A1 (en) 2006-03-31
KR20040096604A (ko) 2004-11-16
CA2477144A1 (en) 2003-08-28
TW200307555A (en) 2003-12-16
CN1635865A (zh) 2005-07-06
RU2309760C2 (ru) 2007-11-10
PL372146A1 (en) 2005-07-11
WO2003070203A1 (en) 2003-08-28
JP2005526038A (ja) 2005-09-02
PT1478329E (pt) 2006-09-29
DK1478329T3 (da) 2006-08-28
AU2003232184B2 (en) 2008-11-13
DE60305159D1 (de) 2006-06-14
AU2003232184A1 (en) 2003-09-09
ATE325604T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
BR0307875A (pt) Composição que pode ser administrada oralmente para a fotoproteção da pele
BR0307839A (pt) Composição fotoprotetora para a pele que pode ser administrada por via oral
BR0317134A (pt) Composições e métodos de liberação de agentes farmacológicos
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BR0313562A (pt) derivados de indol ou benzimidazol para a modulação da ikb-cinase
CY1118017T1 (el) Υποβαλλοντας σε αγωγη την ανεπαρκεια και το ελλειμμα βιταμινης d με 25-υδροξυβιταμινη d2 και 25-υδροξυβιταμινη d3
BR0310099A (pt) método para tratar dislipidemia ou uma doença associada com a dislipidemia
DK1819227T3 (da) Farmaceutisk formulering af decitabin
AR025444A1 (es) Derivados de sulfonil-carboxamida, procedimientos para su preparacion y su utilizacion como medicamentos
BR0214962A (pt) Composição para tratar distúrbios neurocerebrovasculares
NO20060977L (no) Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter
BRPI0612669B8 (pt) composição imunogênica, vacina, composição, e composição liofilizada
BRPI0414565A (pt) composições farmacêuticas e métodos que compreendem combinações de derivados de 2-alquilideno-19-nor-vitamina d e um bisfosfonato
BRPI0507657A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR9912098A (pt) Derivado de tiobenzimidazol, composição farmacêutica, e, agente preventivo e/ou terapêutico
BRPI0411017A (pt) indóis 3-substituìdos e derivados dos mesmos como agentes terapêuticos
BR0307840A (pt) Composição de alimento para animais de estimação para fotoproteção da pele
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
BR0313630A (pt) Composição para aplicação tópica, sistema para o tratamento de caspa, métodos para o tratamento e/ou prevenção da caspa e da coceira do couro cabeludo e usos de uma combinação sinérgica
BR0306258A (pt) Composição, método para tratamento de cabelo e método para manutenção da forma e/ou definição de encaracolamento do cabelo
BRPI0415953B8 (pt) formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada
BRPI0415713A (pt) mio-inositol hexafosfato para uso tópico
NO20061184L (no) Fremgangsmater og blandinger for behandling av herpes-infeksjoner

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/12/2014, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 8/99 (2017.01), A61K 8/31 (2006.01), A61K 31/

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2710 DE 13-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.